🔎 Trials Near Me

Home › Multiple Myeloma › Texas › Austin

Multiple Myeloma clinical trials in Austin, TX

8 studies for Multiple Myeloma are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

RecruitingPhase 3
  • St. David's South Austin Medical Center, Austin
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07258511

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

RecruitingPhase 1/2
  • Research Site, Austin
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05850234

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

RecruitingPhase 1
  • Texas Oncology - Central/South Texas /ID# 268563, Austin
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT05650632

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

RecruitingPhase 4
  • St. David's South Austin Medical Center, Austin
Ages 18 and older · All sexes · Updated Jul 1, 2026 · NCT06057402

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

RecruitingPhase 2
  • Texas Oncology, Austin
Ages 18 and older · All sexes · Updated Apr 22, 2026 · NCT05972135

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

RecruitingObservational studyHealthy volunteers welcome
  • Elligo Health Research, Inc., Austin
Ages 40 and older · All sexes · Updated Jan 20, 2026 · NCT05366881

About Multiple Myeloma

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.

More about Multiple Myeloma on MedlinePlus

Multiple Myeloma trials in other cities

Other studies in Austin

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.